Showing results (171-180 of 214) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Early treatment decisions with interferon-alfa therapy in early chronic-phase chronic myelogenous leukemiaS Sacchi, H M Kantarjian, T L Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabineH M Kantarjian, M J Keating, E H Estey, et al.
Cancer|August 15, 1988
Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high-dose cytosine arabinosideH M Kantarjian, R S Walters, M J Keating, et al.
Leukemia Research|July 21, 1998
Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemiaZ Estrov, M Talpaz, S Ku, et al.
Leukemia|October 27, 1997
Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemiaS Sacchi, H M Kantarjian, S O'Brien, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemiaN Vey, H Kantarjian, H Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998
Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148)M Beran, X Cao, Z Estrov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Response to salvage therapy and survival after relapse in acute myelogenous leukemiaM J Keating, H Kantarjian, T L Smith, et al.
Blood|November 1, 1995
Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phaseS O'Brien, H Kantarjian, M Keating, et al.
The Journal of Biological Chemistry|October 5, 1989
Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase IIL A Zwelling, M Hinds, D Chan, et al.
Pageof 22